Targeting parathyroid hormone level in diabetic patients with stage 3 to 5 chronic kidney disease: does metabolic syndrome matter?

Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation
Rengin ElsurerIdris Yildiz

Abstract

Patients with type 2 diabetes have lower intact parathyroid hormone (iPTH) levels when compared with non-diabetics. Patients with metabolic syndrome (MetSyn) have increased iPTH levels than normal subjects. We hypothesized that patients with type 2 diabetes and MetSyn might have higher iPTH levels as compared with those without MetSyn. The study had an observational design. A total of 84 patients with type 2 diabetes and stage 3 to stage 5 chronic kidney disease (CKD) were recruited (male/female, 40/44). A total of 59 (70.2%) patients had MetSyn. Progress from stage 3 to stage 5 CKD lead to a significant increase in iPTH levels (P-trend = .018). Patients with diabetes and MetSyn had lower high-density lipoprotein cholesterol (P = .018) and higher waist circumference (P = .019), systolic blood pressure (P = .036), fasting plasma glucose (P = .005), HbA1c levels (P = .012), triglyceride (P < .0001), and iPTH (P = .009) as compared with patients without MetSyn. Serum iPTH was negatively correlated with estimated glomerular filtration rate, as measured by Modification of Diet in Renal Disease formula (r = -0.339, P = .002), serum calcium (r = -0.232, P = .037), glucose (r = -0.240, P = .03), and HbA1c (r = -0.301, P = .04) and was ...Continue Reading

References

Jul 1, 1993·Kidney International·Y PeiD Sherrard
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Sep 29, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M InabaY Nishizawa
Aug 12, 2005·Journal of Hypertension·Rolf JordeJohan Sundsfjord
Jul 28, 2007·European Journal of Endocrinology·Thomas ReinehrWerner Andler
Apr 23, 2008·European Journal of Endocrinology·Jared P ReisEdgar R Miller

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Diana C GrootendorstNynke Halbesma
BJOG : an International Journal of Obstetrics and Gynaecology
M C SmithJ M Davison
© 2021 Meta ULC. All rights reserved